| |
China's pharmaceutical companies are gaining prominence. With strong distribution channels within China, many exporting API, and many with shares floating on the Shanghai and other stock markets, Chinese pharmaceutical companies are poised to take a greater share of the global market. This report includes detailed case studies of 20 of China's leading players and provides insights into their operations, strengths and weaknesses, product portfolios, and investment performance.
|
|